Drug profile · INN
insulin aspart-szjj
MERILOG
insulin aspart-szjj (MERILOG) is an FDA-listed pharmaceutical active ingredient. Route of administration: solution. Current US regulatory status: approved.
Drug details — insulin aspart-szjj
- US status
- approved
- Class
- —
- Route
- SOLUTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
insulin aspart-szjj (MERILOG) is an FDA-listed pharmaceutical active ingredient. Route of administration: solution. Current US regulatory status: approved.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Frequently asked questions
What is insulin aspart-szjj?
insulin aspart-szjj (MERILOG) is an FDA-listed pharmaceutical active ingredient. Route of administration: solution. Current US regulatory status: approved.
What is the brand name for insulin aspart-szjj?
MERILOG is a marketed brand name for insulin aspart-szjj. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of insulin aspart-szjj?
insulin aspart-szjj has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.